NeuroKaire

Curated by Signal

Platform offering personalized treatment for psychiatric and neurological conditions

Overview

Platform offering personalized treatment for psychiatric and neurological conditions. It provides solutions for psychiatric and neurological conditions, leveraging stem cell technology, RNA expression, neurobiology, and AI to enable precision medicine in CNS disorders. The platform utilizes a blood test and questionnaire to predict optimal medication for patients with depression, revolutionizing mental health care.

Key facts

Founded: 2017
Headquarters: Kearny, United States
Stage: Sign up to view
Industry: Health Technology

Business model

4 products and services: Sign up to view

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Mentaya
Provider of mental health billing services and streamlined billing solutions for therapists
Health TechnologySan Francisco, United States
AI Lab
AI-based medical imaging and diagnosis tool for providers
Health TechnologyLos Angeles, United States
Harvis Health
Provider of a suite of AI-powered solutions for healthcare providers
Health TechnologyJacksonville, United States

About NeuroKaire

What does NeuroKaire do?

Platform offering personalized treatment for psychiatric and neurological conditions.

Where is NeuroKaire headquartered?

NeuroKaire is headquartered in Kearny, United States.

When was NeuroKaire founded?

NeuroKaire was founded in 2017.

Which sector is NeuroKaire in?

NeuroKaire operates in Health Technology.

Who are NeuroKaire's competitors?

Companies similar to NeuroKaire include Mentaya, AI Lab, and Harvis Health.